WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013053021) ANTIBODIES TO CD1d
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/053021    International Application No.:    PCT/AU2012/001247
Publication Date: 18.04.2013 International Filing Date: 15.10.2012
IPC:
A61K 39/395 (2006.01), C07K 16/28 (2006.01), A61P 11/06 (2006.01), A61P 17/06 (2006.01), A61P 1/16 (2006.01), A61P 9/10 (2006.01), A61P 43/00 (2006.01), C12N 15/13 (2006.01), C12N 5/10 (2006.01)
Applicants: TEVA PHARMACEUTICALS AUSTRALIA PTY LTD. [AU/AU]; Level 2 37 Epping Road Macquarie Park, New South Wales 2113 (AU) (For All Designated States Except US).
NAMBIAR, Jonathan,Kannan [AU/AU]; (AU) (US only).
POULTON, Lynn, Dorothy [AU/AU]; (AU) (US only).
CLARKE, Adam [AU/AU]; (AU) (US only).
POW, Andrew, James [AU/AU]; (AU) (US only).
TAMVAKIS, Debra [AU/AU]; (AU) (US only).
KOPSIDAS, George [AU/AU]; (AU) (US only).
DOYLE, Anthony, Gerard [AU/AU]; (AU) (US only).
POLLARD, Matthew [AU/AU]; (AU) (US only).
MUSTAFA, Huseyin [AU/AU]; (AU) (US only)
Inventors: NAMBIAR, Jonathan,Kannan; (AU).
POULTON, Lynn, Dorothy; (AU).
CLARKE, Adam; (AU).
POW, Andrew, James; (AU).
TAMVAKIS, Debra; (AU).
KOPSIDAS, George; (AU).
DOYLE, Anthony, Gerard; (AU).
POLLARD, Matthew; (AU).
MUSTAFA, Huseyin; (AU)
Agent: DAVIES COLLISON CAVE; Level 15 1 Nicholson Street Melbourne, Victoria 3000 (AU)
Priority Data:
2011904190 14.10.2011 AU
61/547,307 14.10.2011 US
Title (EN) ANTIBODIES TO CD1d
(FR) ANTICORPS DIRIGÉS CONTRE LA CD1D
Abstract: front page image
(EN)The present invention provides isolated antibodies or antigen binding portions thereof which bind to CD1d. These antibodies and antigen binding portions thereof have application in treatment of conditions involving NKT cell effector function.
(FR)La présente invention concerne des anticorps isolés ou des parties de liaison à l'antigène de ceux-ci qui se lient à la molécule CD1d. Ces anticorps ou parties de liaison à l'antigène de ceux-ci ont une application dans le traitement de pathologies impliquant la fonction effectrice des cellules NKT.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)